Insurance

Five things for pharma marketers to know: Monday, December 4, 2017

Five things for pharma marketers to know: Monday, December 4, 2017

By

CVS to buy Aetna for $69 billion; J&J buys commercial rights for biotech's experimental hypertension drug; Republicans repeal Obamacare's individual mandate

Former HealthCare.gov comms staffers fill in for the government with ACA campaign

Former HealthCare.gov comms staffers fill in for the government with ACA campaign

By

Get America Covered is working to encourage consumers to sign up for coverage through the Affordable Care Act.

Five things for pharma marketers to know: Friday, November 10, 2017

Five things for pharma marketers to know: Friday, November 10, 2017

By

AstraZeneca sales fall on generic competition; Anthem broadens access for Duchenne muscular dystrophy drug; researchers are developing new biopsy techniques

Oscar Health launches open enrollment campaign, as funding is slashed for ACA ads

Oscar Health launches open enrollment campaign, as funding is slashed for ACA ads

By

The health insurance startup launched a campaign this week that urges people to get covered.

Why use health plan apps? To search for specialists and understand drug coverage

Why use health plan apps? To search for specialists and understand drug coverage

By

Consumers younger than the age of 45 were most likely to use an app developed by their health plan.

Five things for pharma marketers to know: Wednesday, June 21, 2017

Five things for pharma marketers to know: Wednesday, June 21, 2017

By

Insurance companies balk at expensive PCSK9 inhibitors; Publicis to focus investments on AI platform; clinical trial reveals Novartis' eye drug requires less frequent injections

Genentech urges broader adoption of value-based payment models

Genentech urges broader adoption of value-based payment models

By

A study published in Health Affairs detailed an outcomes-based pilot developed by the drugmaker and Priority Health, a Michigan-based health insurer.

Trump administration raises questions for rare-disease drugmakers

Trump administration raises questions for rare-disease drugmakers

By

Nobody knows what the future holds for the Affordable Care Act under the Trump administration and an emboldened Republican Congress.

Five things for pharma marketers to know: Thursday, November 17, 2016

Five things for pharma marketers to know: Thursday, November 17, 2016

By

Former Valeant and Philidor execs arrested; at least 1 million enroll in 2017 exchange plans; mobile game helps scientists study dementia

Cleveland Clinic's Cosgrove: Obamacare now 'part of the fabric' of the U.S.

Cleveland Clinic's Cosgrove: Obamacare now 'part of the fabric' of the U.S.

By

Cleveland Clinic CEO Toby Cosgrove said at the PRWeek Conference that the pharmaceutical industry has a responsibility to manage drug costs without the government stepping in

Power to the payers: PBMs leave behind a trail of tiers

Power to the payers: PBMs leave behind a trail of tiers

By

When drug costs started to soar, PBMs turned to formulary exclusions — and the industry is still feeling the pinch.

Health exchanges, Obama administration challenged by recent insurer exits

Health exchanges, Obama administration challenged by recent insurer exits

By

The pull-back of insurance providers has left state-run health exchanges and the Obama administration facing a difficult communications challenge.

Five things for pharma marketers to know: Tuesday, August 16, 2016

Five things for pharma marketers to know: Tuesday, August 16, 2016

By

OncoGenex's prostate cancer drug fails in clinical trial; Aetna to exit exchanges in 11 states; pregnant women taking acetaminophen have higher risks for their children

Five things for pharma marketers to know: Wednesday, August 10, 2016

Five things for pharma marketers to know: Wednesday, August 10, 2016

By

A new bill exempting CME reporting gains physician support; NYT op-ed calls Opdivo DTC ad "misleading;" Valeant to sell non-core assets worth $8 billion

Cigna's first global brand campaign targets expats

Cigna's first global brand campaign targets expats

By

The campaign will run in an integrated digital marketing format using channels such as Facebook, Twitter, and Youtube.